Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes and Beyond VI
Mistake 7: Reusing syringes Reusing a syringe to draw from your vial introduces bacteria through the rubber stopper
If you do experience nausea, it typically hits hardest 24 to 48 hours after injection and resolves within a day or two
A registry study in 2020 in the US showed only 40% of the patients with CKD were on ACEi/ ARBs, and smaller similar percentages (around 6%) for SGLT2i and GLP1-RA use (Nicholas, et al, Diabetes Obes Metab, 2023)
Both conditions are linked to lifestyle factors such as poor diet and lack of physical activity, and their prevalence has been increasing steadily
Initially, Semaglutide gained recognition for its efficacy in managing diabetes